8
Participants
Start Date
November 30, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Capecitabine
Given 650 mg/m\^2 BID on days of ration therapy, 825 mg/m\^2 day 1-14, day 15-20 off x 4
Oxaliplatin
Oxaliplatin 30 mg/m\^2, 130mg/m2 IV Q 21 days x 4
Cetuximab
Initial Cetuximab 400 mg/m\^2 IV starting no earlier than 8 weeks and no later than 10 weeks after surgical resection
University of Colorado at Denver and Health Science Center, Aurora
Collaborators (2)
Bristol-Myers Squibb
INDUSTRY
Sanofi
INDUSTRY
University of Colorado, Denver
OTHER